MannKind Corporation (NASDAQ: MNKD) completed its acquisition of scPharmaceuticals Inc. on October 7, 2025, following a tender offer that expired ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE